MS
Mitchell Stephen Ray
Director
BoardM
Insider track record
Board DirectorAcross 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the detailed record of transactions filed by Mitchell Stephen Ray, Director. Insider active across 1 company, notably Vanda Pharmaceuticals Inc.. In total, 12 disclosures have been logged. Split: 0 buy · 3 sells. Total volume traded: €85k. Activity tracked since 10 June 2021. The latest transaction was disclosed on 14 November 2024 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations12 total
5,000 shares@ US$5.17269.3% of flowCommon StockSEC:0000950170-24-128115:0
20,529 shares0Common StockSEC:0000950170-24-063017:0
6,500 shares@ US$6.053713.7% of flowCommon StockSEC:0001209191-23-045447:0
17,307 shares0Common StockSEC:0001209191-23-036285:0
12,006 shares0Common StockSEC:0001209191-22-038448:0
2,700 shares@ US$9.47890.0065% mcap12.2% of flowCommon StockSEC:0001209191-22-036835:0
5,985 shares@ US$10.570.014% mcap26.5% of flowCommon StockSEC:0001209191-21-055685:0
5,985 shares@ US$10.5720.4% of flowCommon StockSEC:0001209191-21-055685
4,015 shares@ US$10.570.0093% mcap17.4% of flowCommon StockSEC:0001209191-21-041496:0
4,015 shares@ US$10.5713.4% of flowCommon StockSEC:0001209191-21-041496
5,000 shares0Common StockSEC:0001209191-21-040240
5,000 shares0Common StockSEC:0001209191-21-040240:0
About Mitchell Stephen Ray
Stephen Ray Mitchell is a Board Member at Vanda Pharmaceuticals Inc. He plays a key role in the governance of the company, bringing his expertise in strategy and product development. His commitment to innovation and operational efficiency is essential in guiding Vanda's strategic decisions.